T

Researcher Profile

Terrence P. Cescon

2

Publications

1,843

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Annals of Oncology Dec 01, 2022

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

C.E. Geyer · J.E. Garber · R.D. Gelber · G. Yothers +562 more

10.1016/j.annonc.2022.09.159 394 citations

Journal Article The Lancet Jan 01, 2019

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E W Cohen · Denis Soulières · Christophe Le Tourneau · José Dinis +99 more

10.1016/s0140-6736(18)31999-8 1,449 citations

Publication Timeline

2022

1

2019

1

Frequent Co-Authors

Laszlo Landherr

Shaker R. Dakhil

Elżbieta Senkus

Giampaolo Bianchini